The Science Behind Injectable Skin Boosters
Skin boosters are a new category of injectables approved by the FDA. These products are low concentration hyaluronic acid gels that improve skin quality, including smoothness, luminosity and hydration. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Terrence Keaney, associate clinical professor of dermatology at GW School of Medicine & …
Skin boosters are a new category of injectables approved by the FDA. These products are low concentration hyaluronic acid gels that improve skin quality, including smoothness, luminosity and hydration. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Terrence Keaney, associate clinical professor of dermatology at GW School of Medicine & … Continue reading "The Science Behind Injectable Skin Boosters"
Cemiplimab is a monoclonal antibody therapy that has emerged as a promising treatment option for certain types of advanced skin cancer. Specifically designed to target the programmed cell death protein 1 (PD-1) pathway, cemiplimab works by blocking the interaction between PD-1 and its ligands, PD-L1 and PD-L2, thereby unleashing the body's immune system to recognize and attack cancer cells. We con … 
CNBC recently wrote an article about the safety of keratin hair treatments in light of a proposed FDA rule that would ban products that contain or release formaldehyde. Which straightening products would be affected by a ban? What should dermatologists know about safety concerns with other hair straightening products?
Amy McMichael, MD, FAAD, professor of dermatology at Wake Forest University S … 
You may want to make an extra effort to encourage your young adult patients to protect their skin from the sun. Recent surveys, as noted in The New York Times, showed that adults born after 1997 – those considered in Gen Z – were more likely to believe sun safety myths, including that daily sunscreen usage is more harmful than sun exposure.
Experts say that misinformation in this age group … 
Histopathology can be rendered useless without good clinical information, according to Dr. Olayemi Sokumbi, a dermatologist and dermatopathologist with Mayo Clinic. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Sokumbi about traps to avoid in challenging clinicopathologic scenarios. Learn how not to miss a diagnosis of dermatomyosit … 